Women News & Analysis
3 articles
Market Mood
Women Investors Achieve 50% Returns Compared to 47% for Men
Women who invest achieve slightly higher long-term returns than men, with cumulative returns of 50% for females compared to 47% for males over three years, according to analysis by Fidelity International. Despite this, only 26% of UK women have investments, compared to 41% of men. The lower investment rate among women may be attributed to cultural factors, as fewer women historically make investment decisions. This data suggests a potential shift in investment behavior, which could impact investment strategies for those considering market participation, particularly for ordinary investors.
Read More: Women Investors Achieve 50% Returns Compared to 47% for Men
Financial Insights: Debt Management and Confidence in Investing
Sarah Reeve required her fiancé Lee to pay off a £2,000 bank loan, about £4,000 in today's money, before their wedding. The couple, together for 25 years, emphasizes joint finances, with Sarah earning £24,000 part-time in insurance and Lee earning approximately £30,000 in property maintenance. A report from St James's Place indicates that more than 80% of women actively manage daily finances, yet only 44% feel confident making investment changes. These insights contribute to understanding gender dynamics in financial management and the importance of financial advice.
Read More: Financial Insights: Debt Management and Confidence in Investing
Estrogen Patch Demand Surges 162% Due to FDA Changes
Prescriptions for estrogen patches have increased by 162% over the past two years, largely due to the FDA's recent removal of a 20-year black box warning on hormone replacement therapy. Despite a surge in demand, manufacturers are struggling to keep up, with shortages reported for three types of patches. The FDA has not officially declared a shortage of estradiol. This increase in prescriptions reflects changing perceptions of menopause treatments and highlights challenges in accessibility for patients.
Read More: Estrogen Patch Demand Surges 162% Due to FDA Changes